liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Antibody-Mediated suppression of Vbeta5.2/5.3+ T Cells in Multiple Sclerosis: Results from an MRI-Monitored Phase II Clinical Trial
Show others and affiliations
2002 (English)In: Annals of Neurology, ISSN 0364-5134, Vol. 51, no 4, 467-474 p.Article in journal (Refereed) Published
Abstract [en]

The objective of this study was to evaluate the safety and efficacy of the humanized antibody ATM-027 in a baseline versus treatment magnetic resonance imaging-monitored study. Expansion of Vß5.2/5.3+ T cells has been demonstrated in the peripheral blood, cerebrospinal fluid, and brain lesions of MS patients. In a phase I study, ATM-027 depleted these cells in peripheral blood and, in parallel, T-cell MBP reactivity and IFN-? expression were reduced. We studied 59 patients with relapsing-remitting MS (47 on ATM-027 and 12 on placebo) stratified for HLA-DR2 status. Monthly intravenous injections were given for 6 months. Individual dose titration was employed to obtain depletion of the target T-cell level and downregulation of antigen receptor density as monitored by flow cytometry. Five monthly magnetic resonance imaging scans were performed before treatment to establish baseline activity, six during treatment, and three during follow-up. Additional immunological assessments were performed to elucidate the mechanism of action of ATM-027. The treatment was safe and well tolerated, inducing consistent suppression of the target cell population. During run-in, active lesions were found in 78.7% (37/47) of patients treated with ATM-027. During treatment, the median number of lesions was reduced by 33% (p = 0.13) independent of DR2 status. The corresponding volume of enhancement was 221 mm3 at baseline, with a reduction of 10% during treatment. Decreased numbers of cells expressing interferon-? messenger RNA, and decreased T-cell reactivity to several myelin antigens were found in ATM-027 treated patients. In conclusion, consistent suppression of Vß 5.2/5.3+ T cells was achieved. However, the effect size on magnetic resonance imaging was considerably less than the targeted 60%.

Place, publisher, year, edition, pages
2002. Vol. 51, no 4, 467-474 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-27837DOI: 10.1002/ana.10146Local ID: 12594OAI: diva2:248389
Available from: 2009-10-08 Created: 2009-10-08 Last updated: 2009-11-01

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Landtblom, Anne-Marie
By organisation
Faculty of Health SciencesDepartment of Neuroscience and LocomotionDepartment of Neurology
In the same journal
Annals of Neurology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 43 hits
ReferencesLink to record
Permanent link

Direct link